Researchers at the University of California San Diego have initiated the first placebo-controlled randomized trial investigating the efficacy of cannabis products for the treatment of acute migraine. Trial participants will be randomized into 4 study groups (placebo, THC only, CBD only, and THC and CBD) and monitored for short-term migraine outcomes such as pain relief and nausea intensity. The study is expected to be completed in late 2021.
First clinical trial for migraine treatment with cannabis announced
Click here to learn how STEM selects new articles.